Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)

Market Cap	22.22B +13.5%
Revenue (ttm)	1.92B +14.2%
Net Income	390.06M +24.2%
EPS	0.66 +24.1%
Shares Out	n/a
PE Ratio	56.42
Forward PE	49.06
Dividend	0.55 (1.46%)
Ex-Dividend Date	Jun 22, 2026

Volume	414,879
Open	37.33
Previous Close	37.33
Day's Range	37.33 - 38.06
52-Week Range	26.51 - 38.06
Beta	0.90
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 24, 2026

About ASX:FPH

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,434
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: FPH

Financial Performance

In fiscal year 2026, ASX:FPH's revenue was 2.31 billion, an increase of 14.22% compared to the previous year's 2.02 billion. Earnings were 468.50 million, an increase of 24.20%.

Financial numbers in NZD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 7, 2026

Data Sources Report a data error